Canaccord Genuity analyst William Plovanic maintained a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of $269.00. William Plovanic has given his Buy rating due to a ...
5 The 1980s were a particularly strong time for diabetes awareness and research, in part due to insulin made of recombinant DNA and the availability of at-home products that allowed patients to test ...